drugset / Trial / NCT07154264
A Study of DZD8586 Combination in CLL/SLL (TAI-SHAN10)
NaSingle-groupOpen-labelTreatment
Summary
This is a phase 2 study to investigate the efficacy and safety of DZD8586 in combination in participants with CLL/SLL. This study consists of two parts: Part A is the safety lead-in phase, and Part B is the dose expansion phase.
Timeline
- Start
- 2025-09-22
- Primary completion
- 2029-12
- Completion
- 2030-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | DZD8586 | Unknown | — | Oral |
| Subject | Venetoclax | Small molecule | — | Oral |